Case number 1:21-cv-01735
Gilead Sciences, Inc. v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2022 | 15 | Terminated Case (2) Docket Text: ORDER Dismissing Case Without Prejudice, re [14] Stipulation of Dismissal filed by Gilead Sciences, Inc. (CASE CLOSED) Signed by Judge William C. Bryson on 04/15/2022. (smg) |
| Apr 15, 2022 | 16 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,377,933 B2 ; 9,474,752 B2 ; 9,549,926 B2. (smg) |
| Apr 14, 2022 | 14 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal and [Proposed] Order (Joint) by Gilead Sciences, Inc.. (Tigan, Jeremy) |
| Mar 30, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The scheduling conference scheduled for April 1, 2022, at 2:00 p.m. has been moved to Monday, April 18, 2022, at 2:00 p.m. The plaintiffs will be responsible for obtaining a court reporter for the scheduling conference. The cost will be shared equally between the parties. The court will host the telephonic conference, and shortly before the date for the conference, dial-in information will be provided by email to all counsel of record. The parties status report regarding scheduling is now due by Friday, April 15, 2022, at 3:00 p.m. Eastern Time. Signed by Judge William C. Bryson on 3/30/22. (mal) |
| Mar 16, 2022 | 12 | Order Setting Scheduling Conference (11) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 4/1/2022 at 02:00PM ET telephonically before Judge William C. Bryson. Shortly before the date for the conference, dial-in information will be provided by email to all counsel of record. In the interim, if counsel have questions regarding the scheduling conference or other matters, they can contact my law clerk, Mr. Dane Sowers, at sowersd@cafc.uscourts.gov. Signed by Judge William C. Bryson on 3/16/2022. (nmg) |
| Mar 8, 2022 | 11 | Answer to Counterclaim (7) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Gilead Sciences, Inc..(Tigan, Jeremy) |
| Mar 3, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. (rjb) |
| Feb 14, 2022 | 9 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Gilead Sciences, Inc. by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Feb 14, 2022 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Dec 28, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Aurobindo Pharma Ltd. waiver sent on 12/16/2021, answer due 2/14/2022. (Tigan, Jeremy) |
| Dec 28, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Aurobindo Pharma USA, Inc. waiver sent on 12/16/2021, answer due 2/14/2022. (Tigan, Jeremy) |
| Dec 15, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Dec 10, 2021 | 1 | Main Document (24) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3760146.) - filed by Gilead Sciences, Inc. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(apk) |
| Dec 10, 2021 | 1 | Exhibit A-C (82) |
| Dec 10, 2021 | 1 | Civil Cover Sheet (1) |
| Dec 10, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Dec 10, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/28/21. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 4/28/2024. (apk) |
| Dec 10, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,377,933 B2 ;9,474,752 B2 ;9,549,926 B2. (apk) |
| Dec 10, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (apk) |
| Dec 10, 2021 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 12/10/2021; Aurobindo Pharma USA, Inc. on 12/10/2021. (Attachments: # (1) Summons Issued)(apk) |
| Dec 10, 2021 | 6 | Summons Issued (2) |
| Dec 10, 2021 | 1 | Complaint* (1) |
